Smoking and Cytisine
Smoking is a common problem in peripheral vascular disease patients in India. Behavioural therapy programs are not popular in Indian medical practice. Most of the time it is the doctor who tells patients and at times threatens the patients explaining about the side effects of smoking. Rarely pharmacological intervention is asked by the patients. There is a fear that pharmaco-therapy is more expensive. Cytisine, a partial agonist that binds with high affinity to the α4β2 nicotinic acetylcholine receptor, is a low-cost treatment that may be effective in aiding smoking cessation.
The lower price of cytisine as compared with that of other pharmacotherapies for smoking cessation may make it an affordable treatment to advance smoking cessation globally. A randomized study is published in NEJM recently and that is supporting the role of cytisine in smoking cessation.
Pinjala R K
1st Oct 2011
Smoking is a common problem in peripheral vascular disease patients in India. Behavioural therapy programs are not popular in Indian medical practice. Most of the time it is the doctor who tells patients and at times threatens the patients explaining about the side effects of smoking. Rarely pharmacological intervention is asked by the patients. There is a fear that pharmaco-therapy is more expensive. Cytisine, a partial agonist that binds with high affinity to the α4β2 nicotinic acetylcholine receptor, is a low-cost treatment that may be effective in aiding smoking cessation.
The lower price of cytisine as compared with that of other pharmacotherapies for smoking cessation may make it an affordable treatment to advance smoking cessation globally. A randomized study is published in NEJM recently and that is supporting the role of cytisine in smoking cessation.
Pinjala R K
1st Oct 2011
No comments:
Post a Comment